Company profile

Endolytix company profile

Endolytix is a biotech company that develops therapeutic approaches that address intrinsic antibiotic resistance in NTM infections. Its therapeutics kill pathogenic bacteria, including multidrug-resistant bacteria, and help the healthcare industry address the most resistant antibiotic infections that are difficult to access and treat.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2020-01-01

Headquarters

Headquarters
Beverly, Massachusetts, United States
Postal code
01915
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$12M
Last funding
Debt Financing / $5M / 2024-08-07
Last equity funding
Series Unknown / $12M
Investors
1
Founders
1
Articles
9

Founders and investors

Founders

Jason Holder

Investors

Morningside

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.